Chirag Patel is Co-Chief Executive Officer and President of Amneal Pharmaceuticals, Inc. (AMRX). The company reported total compensation of $8,691,745 for fiscal year 2025.
| Salary | $800,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $6,974,995 |
| Option awards | $0 |
| Non-equity incentive plan | $848,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $68,750 |
| Total | $8,691,745 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Amneal Pharmaceuticals, Inc. filed March 25, 2026, accession 0001308179-26-000143.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Chirag Patel this page | Co-Chief Executive Officer and President | $8,691,745 |
| Anastasios Konidaris | EVP & Chief Financial Officer | $3,293,494 |
| Andrew Boyer | EVP, Chief Commercial Officer - Generics | $3,017,163 |
| Jason Daly | EVP, Chief Legal Officer & Secretary | $2,860,442 |
| Nikita Shah | EVP, Chief Human Resources Officer | $2,730,582 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Amneal Pharmaceuticals, Inc. compensation brief.
Chirag Patel's compensation sits inside Amneal Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.